Continuing coverage: An FDA-approved drug initially used to treat insulin resistance in diabetics has shown promise as a way to improve cognitive performance in some people with Alzheimer’s disease. Working with genetically engineered mice designed to serve as models for Alzheimer’s, UTMB researchers Larry Denner and Kelly Dineley found that treatment with the drug Avandia enhanced learning and memory as well as normalized insulin resistance.